Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297)

• Status: Completed
• Trial end date: 2005-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to look at the preliminary safety profile of an investigational drug in children 1 to < 3 months of age with bronchiolitis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Montelukast

Criteria

Inclusion Criteria :

• Active bronchiolitis and a history of bronchiolitis and asthma-like symptoms.

Exclusion Criteria :

• Anemia or history of any significant illness that will pose additional risk to the patient.